Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recommendations for surveillance of pulmonary dysfunction among childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
Otth M, Kasteler R, Mulder RL, Agrusa J, Armenian SH, Barnea D, Bergeron A, Bhatt NS, Bourke SJ, Constine LS, Goutaki M, Green DM, Hennewig U, Houdouin V, Hudson MM, Kremer L, Latzin P, Ng A, Oeffinger KC, Schindera C, Skinner R, Sommer G, Srinivasan S, Stokes DC, Versluys B, Waespe N, Weiner DJ, Dietz AC, Kuehni CE. Otth M, et al. Among authors: versluys b. EClinicalMedicine. 2024 Feb 20;69:102487. doi: 10.1016/j.eclinm.2024.102487. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38420219 Free PMC article. Review.
Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study.
Clemens E, de Vries AC, Pluijm SF, Am Zehnhoff-Dinnesen A, Tissing WJ, Loonen JJ, van Dulmen-den Broeder E, Bresters D, Versluys B, Kremer LC, van der Pal HJ, van Grotel M, van den Heuvel-Eibrink MM; DCOG-LATER, The Netherlands. Clemens E, et al. Among authors: versluys b. Eur J Cancer. 2016 Dec;69:77-85. doi: 10.1016/j.ejca.2016.09.023. Epub 2016 Nov 4. Eur J Cancer. 2016. PMID: 27821322
Hearing loss after platinum treatment is irreversible in noncranial irradiated childhood cancer survivors.
Clemens E, de Vries AC, Am Zehnhoff-Dinnesen A, Tissing WJ, Loonen JJ, Pluijm SF, van Dulmen-den Broeder E, Bresters D, Versluys B, Kremer LC, van der Pal HJ, Neggers SJ, van Grotel M, M van den Heuvel-Eibrink M. Clemens E, et al. Among authors: versluys b. Pediatr Hematol Oncol. 2017 Mar;34(2):120-129. doi: 10.1080/08880018.2017.1323985. Epub 2017 Jun 7. Pediatr Hematol Oncol. 2017. PMID: 28590156 Clinical Trial.
Metabolic Syndrome Parameters, Determinants, and Biomarkers in Adult Survivors of Childhood Cancer: Protocol for the Dutch Childhood Cancer Survivor Study on Metabolic Syndrome (Dutch LATER METS).
Pluimakers V, Fiocco M, van Atteveld J, Hobbelink M, Bresters D, Van Dulmen-den Broeder E, Van der Heiden-van der Loo M, Janssens GO, Kremer L, Loonen J, Louwerens M, Van der Pal H, Ronckers C, Van Santen H, Versluys B, De Vries A, Van den Heuvel-Eibrink M, Neggers S. Pluimakers V, et al. Among authors: versluys b. JMIR Res Protoc. 2021 Jan 27;10(1):e21256. doi: 10.2196/21256. JMIR Res Protoc. 2021. PMID: 32750002 Free PMC article.
A vulnerable age group: the impact of cancer on the psychosocial well-being of young adult childhood cancer survivors.
van Erp LME, Maurice-Stam H, Kremer LCM, Tissing WJE, van der Pal HJH, de Vries ACH, van den Heuvel-Eibrink MM, Versluys BAB, van der Heiden-van der Loo M, Huizinga GA, Grootenhuis MA. van Erp LME, et al. Among authors: versluys bab. Support Care Cancer. 2021 Aug;29(8):4751-4761. doi: 10.1007/s00520-021-06009-y. Epub 2021 Feb 1. Support Care Cancer. 2021. PMID: 33527229 Free PMC article.
Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function.
van der Kooi ALF, van Dijk M, Broer L, van den Berg MH, Laven JSE, van Leeuwen FE, Lambalk CB, Overbeek A, Loonen JJ, van der Pal HJ, Tissing WJ, Versluys B, Bresters D, Beerendonk CCM, Ronckers CR, van der Heiden-van der Loo M, Kaspers GL, de Vries ACH, Robison LL, Hudson MM, Chemaitilly W, Byrne J, Berger C, Clemens E, Dirksen U, Winther JF, Fosså SD, Grabow D, Haupt R, Kaiser M, Kepak T, Kruseova J, Modan-Moses D, Pluijm SMF, Spix C, Zolk O, Kaatsch P, Krijthe JH, Kremer LC, Yasui Y, Brooke RJ, Uitterlinden AG, van den Heuvel-Eibrink MM, van Dulmen-den Broeder E. van der Kooi ALF, et al. Among authors: versluys b. Hum Reprod. 2021 Mar 18;36(4):1120-1133. doi: 10.1093/humrep/deaa342. Hum Reprod. 2021. PMID: 33582778 Free PMC article.
Development and Validation of a Breast Cancer Risk Prediction Model for Childhood Cancer Survivors Treated With Chest Radiation: A Report From the Childhood Cancer Survivor Study and the Dutch Hodgkin Late Effects and LATER Cohorts.
Moskowitz CS, Ronckers CM, Chou JF, Smith SA, Friedman DN, Barnea D, Kok JL, de Vries S, Wolden SL, Henderson TO, van der Pal HJH, Kremer LCM, Neglia JP, Turcotte LM, Howell RM, Arnold MA, Schaapveld M, Aleman B, Janus C, Versluys B, Leisenring W, Sklar CA, Begg CB, Pike MC, Armstrong GT, Robison LL, van Leeuwen FE, Oeffinger KC. Moskowitz CS, et al. Among authors: versluys b. J Clin Oncol. 2021 Sep 20;39(27):3012-3021. doi: 10.1200/JCO.20.02244. Epub 2021 May 28. J Clin Oncol. 2021. PMID: 34048292 Free PMC article.
Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study.
van der Perk MEM, Broer L, Yasui Y, Robison LL, Hudson MM, Laven JSE, van der Pal HJ, Tissing WJE, Versluys B, Bresters D, Kaspers GJL, de Vries ACH, Lambalk CB, Overbeek A, Loonen JJ, Beerendonk CCM, Byrne J, Berger C, Clemens E, Dirksen U, Winther JF, Fosså SD, Grabow D, Muraca M, Kaiser M, Kepák T, Kruseova J, Modan-Moses D, Spix C, Zolk O, Kaatsch P, Krijthe JH, Kremer LCM, Brooke RJ, Baedke JL, van Schaik RHN, van den Anker JN, Uitterlinden AG, Bos AME, van Leeuwen FE, van Dulmen-den Broeder E, van der Kooi ALF, van den Heuvel-Eibrink MM, On Behalf Of The PanCareLIFE Consortium. van der Perk MEM, et al. Among authors: versluys b. Cancers (Basel). 2021 Sep 13;13(18):4598. doi: 10.3390/cancers13184598. Cancers (Basel). 2021. PMID: 34572825 Free PMC article.
Clinical evaluation of late outcomes in Dutch childhood cancer survivors: Methodology of the DCCSS LATER 2 study.
Feijen EAM, Teepen JC, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van der Heiden-van der Loo M, van der Pal HJH, de Vries ACH, Louwerens M, Bresters D, Versluys B, de Ridder H, Veening M, van Leeuwen FE, Grootenhuis M, Maurice-Stam H, van Santen HM, Neggers SJCMM, Pluijm S, den Hartogh J, Ronckers CM, Tissing WJE, Loonen JJ, Kremer LCM. Feijen EAM, et al. Among authors: versluys b. Pediatr Blood Cancer. 2023 May;70(5):e30212. doi: 10.1002/pbc.30212. Epub 2023 Jan 18. Pediatr Blood Cancer. 2023. PMID: 36651687
A joint international consensus statement for measuring quality of survival for patients with childhood cancer.
van Kalsbeek RJ, Hudson MM, Mulder RL, Ehrhardt M, Green DM, Mulrooney DA, Hakkert J, den Hartogh J, Nijenhuis A, van Santen HM, Schouten-van Meeteren AYN, van Tinteren H, Verbruggen LC, Conklin HM, Jacola LM, Webster RT, Partanen M, Kollen WJW, Grootenhuis MA, Pieters R, Kremer LCM; International Childhood Cancer Outcome Project participants. van Kalsbeek RJ, et al. Nat Med. 2023 Jun;29(6):1340-1348. doi: 10.1038/s41591-023-02339-y. Epub 2023 Jun 15. Nat Med. 2023. PMID: 37322119 Review.
62 results